BIIB vs PEP · P/E 21, rev $9.89B vs P/E 22, rev $43.62B
Biogen Inc (BIIB) versus PepsiCo Inc (PEP) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
PepsiCo Inc (PEP) is a beverages - non-alcoholic company listed on NASDAQ. It is led by Ramon Luis Laguarta.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported PEP revenue for 2026-06-13 was $43.62B. Net income was $5.31B. PEP currently screens at market cap $193.55B and trailing P/E 22.2.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. PEP currently screens at market cap $193.55B and trailing P/E 22.2.
Not investment advice. Open the BIIB and PEP stock pages for the full models.
Not investment advice.